Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
US Army
QuintilesIMS
Colorcon
Healthtrust
Cipla
Citi
Harvard Business School
Cerilliant

Generated: January 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for SUVN-502

« Back to Dashboard

US Patents for SUVN-502

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SUVN-502 ➤ Try a Free Trial Tetracyclic 3-substituted indoles having serotonin receptor affinity Suven Life Sciences Limited (Hyderabad, Adhra Pradesh, IN) ➤ Try a Free Trial
SUVN-502 ➤ Try a Free Trial N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them Suven Life Sciences Limited (IN) ➤ Try a Free Trial
SUVN-502 ➤ Try a Free Trial Process for large scale production of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-- 1H-indole dimesylate monohydrate SUVEN LIFE SCIENCES LIMITED (Hyderbad, IN) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for SUVN-502

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
SUVN-502 Austria 355292 1989-12-31 ➤ Try a Free Trial
SUVN-502 Australia 2003292510 1989-12-31 ➤ Try a Free Trial
SUVN-502 Brazil 0316895 1989-12-31 ➤ Try a Free Trial
SUVN-502 Canada 2507923 1989-12-31 ➤ Try a Free Trial
SUVN-502 China 100378109 1989-12-31 ➤ Try a Free Trial
SUVN-502 China 1729197 1989-12-31 ➤ Try a Free Trial
SUVN-502 Germany 60312226 1989-12-31 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Harvard Business School
UBS
US Army
Fuji
Accenture
Merck
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: